Policy Developments - The Ministry of Industry and Information Technology, along with two other departments, announced the initiation of the 2025 high-end medical equipment promotion application project [1] Drug and Device Approvals - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, aimed at treating cancer pain in adults, with no similar drugs currently on the market [2] - Heng Rui Medicine's subsidiary received approval for clinical trials of HRS-2129, targeting diabetic peripheral neuropathic pain and osteoarthritis pain, with a total R&D investment of approximately 112 million yuan [3] - Borui Pharmaceutical obtained FDA approval for the clinical trial of BGM1812 injection for overweight or obesity treatment, with no similar products approved globally [4] Capital Market - Hangzhou Yaojiasu Medical Isotope Technology Co., Ltd. announced the completion of several million yuan in angel round financing, aimed at expanding its core team and advancing technology development [5] Industry Events - The National Medical Insurance Administration has identified and addressed multiple cases of abnormal data, enhancing the regulatory capabilities of medical insurance data [7] - Xiangyu Medical signed a cooperation agreement with Zhejiang Provincial People's Hospital to establish a clinical research ward for brain-machine interfaces [8] - A micro "lung chip" with an embedded immune system was developed by researchers from Georgia Tech and Vanderbilt University, potentially revolutionizing disease research [9] Public Opinion Alerts - Shenqi Pharmaceutical faced a significant stock drop after being ordered to rectify issues related to the misappropriation of 44.83 million yuan in sales fees, leading to regulatory actions [10]

人民财讯9月29日电，工业和信息化部、国家卫生健康委、国家药监局三部门近日印发通知，组织开展 2025年高端医疗装备推广应用项目申报工作。本次推广应用项目重点面向高端医疗装备重点产品和典型 场景，遴选一批技术创新水平与临床应用水平处于全国前列，对医工协同创新、中试验证、临床研究、 迭代升级与推广应用等具有较强引领带动作用的项目。本年度重点开展5类重点产品和4类典型场景的推 广应用。 ...

通知指出，为深入贯彻健康中国、制造强国战略部署，加快推进高端医疗装备创新发展，开展新技术新 产品新场景大规模应用，现就 2025 年度高端医疗装备推广应用项目申报工作有关事项通知如下：面向 高端医疗装备重点产品和典型场景，遴选一批技术创新水平与临床应用水平处于全国前列，对医工协同 创新、中试验证、临床研究、迭代升级与推广应用等具有较强引领带动作用的项目。本年度重点开展 5 类重点产品和 4 类典型场景的推广应用。 智通财经APP获悉，工业和信息化部办公厅 、国家卫生健康委办公厅、 国家药监局综合和规划财务司 发布关于开展 2025 年高端医疗装备推广应用项目申报工作的通知。 招商证券国际发布研报称，2025年上半年，内地医疗器械行业整体收入同比跌3.8%，归母净利润同比 跌12.8%;扣非净利润同比跌14.5%。第二季单季收入同比跌5.5%，归母净利润同比跌20.3%，扣非净利 润同比降25%。 该行以港股和A股上市的129家医疗器械公司为样本，经过分析发现上半年约53%的公司收入实现同比 增长，增速超20%占比16%，增速处于0-20%区间占比37%。 该行认为，经历过疫情及国内集采双重政策扰动后，整体器械 ...